Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
After finishing at $1.35 in the prior trading day, Ocugen Inc (NASDAQ: OCGN) closed at $1.38, up 2.22%. In other words, the price has increased by $2.22 from its previous closing price. On the day, 2.55 million shares were traded. OCGN stock price reached its highest trading level at $1.39 during the session, while it also had its lowest trading level at $1.33.
Ratios:
Our goal is to gain a better understanding of OCGN by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.85 and its Current Ratio is at 1.85. In the meantime, Its Debt-to-Equity ratio is 9.34 whereas as Long-Term Debt/Eq ratio is at 9.10.
Upgrades & Downgrades
In the most recent recommendation for this company, Maxim Group on October 15, 2024, initiated with a Buy rating and assigned the stock a target price of $4.
On March 01, 2023, Chardan Capital Markets Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $3.50.
On August 23, 2022, Mizuho started tracking the stock assigning a Buy rating and target price of $5.Mizuho initiated its Buy rating on August 23, 2022, with a $5 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jul 09 ’25 when MARNA C. WHITTINGTON bought 112,205 shares for $1.10 per share.
PRABHAVATHI FERNANDES bought 146,705 shares of OCGN for $171,029 on Jun 11 ’25.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OCGN now has a Market Capitalization of 431001760 and an Enterprise Value of 431400768. For the stock, the TTM Price-to-Sale (P/S) ratio is 80.26 while its Price-to-Book (P/B) ratio in mrq is 122.02. Its current Enterprise Value per Revenue stands at 80.335 whereas that against EBITDA is -7.502.
Stock Price History:
The Beta on a monthly basis for OCGN is 3.50, which has changed by 0.5333333 over the last 52 weeks, in comparison to a change of 0.14778805 over the same period for the S&P500. Over the past 52 weeks, OCGN has reached a high of $1.90, while it has fallen to a 52-week low of $0.51. The 50-Day Moving Average of the stock is 2.88%, while the 200-Day Moving Average is calculated to be 24.96%.
Shares Statistics:
The stock has traded on average 4.25M shares per day over the past 3-months and 3722240 shares per day over the last 10 days, according to various share statistics. A total of 312.32M shares are outstanding, with a floating share count of 307.65M. Insiders hold about 1.49% of the company’s shares, while institutions hold 21.07% stake in the company. Shares short for OCGN as of 1765756800 were 58994853 with a Short Ratio of 13.87, compared to 1763078400 on 59091529. Therefore, it implies a Short% of Shares Outstanding of 58994853 and a Short% of Float of 19.18.
Earnings Estimates
A detailed examination of Ocugen Inc (OCGN) is currently in progress, with 4.0 analysts providing valuable insights into its market dynamics.The consensus estimate for the next quarter is -$0.06, with high estimates of -$0.05 and low estimates of -$0.07.
Analysts are recommending an EPS of between -$0.22 and -$0.23 for the fiscal current year, implying an average EPS of -$0.23. EPS for the following year is -$0.24, with 4.0 analysts recommending between -$0.17 and -$0.29.
Revenue Estimates
A total of 5 analysts have provided revenue estimates for OCGN’s current fiscal year. The highest revenue estimate was $6.1M, while the lowest revenue estimate was $4.61M, resulting in an average revenue estimate of $5.4M. In the same quarter a year ago, actual revenue was $4.05M
